The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Sep 2017 13:00

RNS Number : 5918R
Carillion PLC
22 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Carillion Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Deutsche Bank AG

City and country of registered office (if applicable)

Frankfurt, Germany

4. Full name of shareholder(s) (if different from 3.)v

Name

Deutsche Bank AG, London Branch

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

20.09.2017

6. Date on which issuer notified (DD/MM/YYYY):

22.09.2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.85%

4.01%

7.86%

430,254,629

Position of previous notification (if

applicable)

4.29%

3.83%

8.12%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0007365546

16,561,114

0

3.85%

0%

SUBTOTAL 8. A

16,561,114

3.85%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Right To Recall

1,089,000

0.25%

SUBTOTAL 8. B 1

1,089,000

0.25%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Swaps - Equity

03.01.2020

Cash

16,185,053

3.76%

SUBTOTAL 8.B.2

16,185,053

3.76%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Birmingham

Date of completion

22.09.2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFELAAIFFID
Date   Source Headline
1st Mar 20177:00 amRNSFinal Results
2nd Feb 20174:25 pmRNSHolding(s) in Company
2nd Feb 20177:00 amRNSCarillion Extends Openreach Framework Agreement
30th Jan 20173:42 pmRNSCarillion refinances maturing debt facilities
23rd Jan 20173:25 pmRNSHolding(s) in Company
20th Jan 201712:46 pmRNSHolding(s) in Company
19th Jan 20179:20 amRNSDirectorate Change
4th Jan 20177:00 amRNSCarillion JV awarded £160 million contract
20th Dec 20169:29 amRNSBlock listing Interim Review
16th Dec 201612:37 pmRNSHolding(s) in Company
16th Dec 20168:09 amRNSHolding(s) in Company
15th Dec 20168:15 amRNSHolding(s) in Company
7th Dec 20164:46 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSCarillion selected as the preferred bidder
7th Dec 20167:00 amRNSFull year trading update
6th Dec 20165:36 pmRNSHolding(s) in Company
5th Dec 20164:06 pmRNSHolding(s) in Company
2nd Dec 20163:46 pmRNSHolding(s) in Company
2nd Dec 20162:45 pmRNSHolding(s) in Company
29th Nov 201611:03 amRNSHolding(s) in Company
4th Nov 201610:49 amRNSDirector/PDMR Shareholding
1st Nov 20161:30 pmRNSCarillion Joint Ventures awarded contract by MoD
25th Oct 20167:42 amRNSHolding(s) in Company
21st Oct 20169:37 amRNSHolding(s) in Company
6th Oct 20167:58 amRNSHolding(s) in Company
4th Oct 20167:00 amRNSCarillion wins £350m contract for Nationwide
15th Sep 20167:44 amRNSHolding(s) in Company
5th Sep 20167:00 amRNSCarillion selected by Centrica for contract
24th Aug 20167:05 amRNSHalf-year Report
24th Aug 20167:00 amRNSDirectorate Change
15th Aug 20161:56 pmRNSHolding(s) in Company
29th Jul 20169:16 amRNSHolding(s) in Company
26th Jul 20161:16 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSCarillion subsidiary in joint venture
26th Jul 20167:00 amRNSCarillion joint venture achieves financial close
22nd Jul 20162:59 pmRNSHolding(s) in Company
20th Jul 20166:01 pmRNSHolding(s) in Company
18th Jul 20164:43 pmRNSHolding(s) in Company
15th Jul 20169:35 amRNSHolding(s) in Company
14th Jul 20163:58 pmRNSHolding(s) in Company
14th Jul 20162:30 pmRNSHolding(s) in Company
14th Jul 20167:41 amRNSHolding(s) in Company
13th Jul 20162:44 pmRNSHolding(s) in Company
13th Jul 20169:51 amRNSHolding(s) in Company
12th Jul 20163:25 pmRNSHolding(s) in Company
8th Jul 20168:01 amRNSHolding(s) in Company
6th Jul 20167:00 amRNSCarillion awarded contracts worth up to £600m
6th Jul 20167:00 amRNSHALF-YEAR TRADING UPDATE
29th Jun 20167:54 amRNSHolding(s) in Company
29th Jun 20167:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.